Roche and Diagnostica Stago terminate partnership
Roche Professional Diagnostics and Diagnostica Stago announced that the companies have decided to pursue separate paths in the business of Laboratory Coagulation in the territories where Roche distributed the Stago product range. The exclusive sales of Stago products by Roche will continue throughout the entire year of 2011.With the exception of Japan where Roche Diagnostics Japan will continue to distribute the Stago portfolio within the Japanese market under a separate agreement, Stago will sell its products directly or through other distribution channels.
Stago and Roche have an agreement to ensure that all contractual obligations regarding Stago products that Roche has or will enter into can be fulfilled by Roche during the agreed upon three year transition period.
“The arrangements between Stago and Roche provide our customers with a secure way forward. We have made sure that product supply continues without interruption, and customers can rely on both Roche and Stago to continue to fulfill their needs in laboratory coagulation”, said Colin Brown, Head of Roche Professional Diagnostics.
Bertrand Bonnot, COO of Stago, said "We are convinced that, after almost 40 years of successful partnership, it is the right timing for both companies to follow independent paths. Nevertheless, both Stago and Roche are committed to work together to ensure a seamless transition in the coming years.”
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
